Cargando…
The ATP-Gated P2X7 Receptor As a Target for the Treatment of Drug-Resistant Epilepsy
Despite the progress made in the development of new antiepileptic drugs (AEDs), the biggest challenges that epilepsy presents to drug development have remained unchanged for the last 80 years: finding a treatment with potential for modifying disease progression and reducing the percentage of patient...
Autores principales: | Beamer, Edward, Fischer, Wolfgang, Engel, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288361/ https://www.ncbi.nlm.nih.gov/pubmed/28210205 http://dx.doi.org/10.3389/fnins.2017.00021 |
Ejemplares similares
-
ATP-gated P2X receptors in health and disease
por: Burnstock, Geoffrey, et al.
Publicado: (2014) -
The Metabotropic Purinergic P2Y Receptor Family as Novel Drug Target in Epilepsy
por: Alves, Mariana, et al.
Publicado: (2018) -
ATP and adenosine—Two players in the control of seizures and epilepsy development
por: Beamer, Edward, et al.
Publicado: (2021) -
New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors
por: Peverini, Laurie, et al.
Publicado: (2018) -
The P2X7 Receptor as a Mechanistic Biomarker for Epilepsy
por: Engel, Tobias
Publicado: (2023)